5-(2-furyl)-N-propylisoxazole-3-carboxamide
CAS No. 907989-92-8
5-(2-furyl)-N-propylisoxazole-3-carboxamide( —— )
Catalog No. M28400 CAS No. 907989-92-8
5-(2-furyl)-N-propylisoxazole-3-carboxamide is a compound used as a molecular building block.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 45 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 64 | In Stock |
|
| 25MG | 109 | In Stock |
|
| 50MG | 161 | In Stock |
|
| 100MG | 242 | In Stock |
|
| 200MG | 352 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-(2-furyl)-N-propylisoxazole-3-carboxamide
-
NoteResearch use only, not for human use.
-
Brief Description5-(2-furyl)-N-propylisoxazole-3-carboxamide is a compound used as a molecular building block.
-
Description5-(2-furyl)-N-propylisoxazole-3-carboxamide is a compound used as a molecular building block.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorHDAC6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number907989-92-8
-
Formula Weight220.228
-
Molecular FormulaC11H12N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCNC(=O)c1cc(on1)-c1ccco1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shen S, et al. Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models. J Med Chem. 2019 Sep 4.
molnova catalog
related products
-
Exo-1
Methyl 3-(4-fluorobenzoyl)-6-methyl-2-pyridinecarboxylate is a chemical compound.
-
(D-Arg1,D-Pro2,D-Phe...
(D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P is a selective NK1 receptor antagonist.
-
PLH1215
PLH1215 is an effective AHR inhibitor that can be used to modulate, limit, or suppress the expression of AVIL (advillin). PLH1215 can be employed for the prevention and treatment of cancer.
Cart
sales@molnova.com